Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 776-800 of 2,022
OngoingEUCTR 2021-001333-38

Cognitive effects of adjuntive Vortioxetine in early Schizophrenia

This study is looking at whether BRINTELLIX can help people with Early schizophrenia. Participants receive the study medicine BRINTELLIX and complete study visits and assessments.

SchizophreniaOther
Countries
Spain
Sponsor
Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI)
Condition
Schizophrenia
OngoingEUCTR 2017-001170-42

An adaptive Phase II/III, Double-Blind, Randomized, Placebo-controlled, Two-Part, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase In...

This study is comparing SODIUM BENZOATE with placebo for people with Treatment for Refractory Schizophrenia in. Participants receive SODIUM BENZOATE or placebo and complete study visits and assessments.

SchizophreniaOther
Countries
Germany, United Kingdom, Poland
Sponsor
SyneuRx International (Taiwan) Corp
Condition
Schizophrenia
CompletedEUCTR 2017-001168-39

An Adaptive, Phase IIb/III, Double-Blind, Randomized, Placebo- Controlled, Multi-Center Study of the Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase Inhibitor, as an Add-on ...

This study is comparing SODIUM BENZOATE with placebo for people with Treatment for Schizophrenia in Adolescents or Adolescents, Under 18. Participants receive SODIUM BENZOATE or placebo and complete study visits and assessments.

SchizophreniaOther
Countries
Poland, United Kingdom
Sponsor
SyneuRx International (Taiwan) Corp
Condition
Schizophrenia
OngoingEUCTR 2017-001169-26

An Adaptive, Phase IIb/III, Multi-center, Prospective, Randomized, Double-Blind Placebo-controlled Study of the Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase Inhibitor, as...

This study is comparing SODIUM BENZOATE with placebo for people with Treatment for Schizophrenia in. Participants receive SODIUM BENZOATE or placebo and complete study visits and assessments.

SchizophreniaOther
Countries
United Kingdom, Poland
Sponsor
SyneuRx International (Taiwan) Corp
Condition
Schizophrenia
OngoingEUCTR 2007-007538-21

A Multi-center, Inpatient and ambulatory, Phase 2, Double-blind, Randomised, Placebo-controlled Proof of Concept Study of CYR-101 in Patients with DSM-IV Schizophrenia

This study is looking at care and outcomes for people with Diagnosis of Schizophrenia in Male or female, as defined in Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Text Revised and confirmed by the St. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOther
Countries
France
Sponsor
CYRENAIC
Condition
Schizophrenia
OngoingEUCTR 2018-002740-82

A phase II randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily with adjunctive Computerized Cognitive Training over 12 wee...

This study is looking at care and outcomes for people with schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOther
Countries
United Kingdom, View results
Sponsor
Boehringer Ingelheim Limited
Condition
Schizophrenia
OngoingEUCTR 2017-001739-38

A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate Pharmacodynamic Effects, Safety, Tolerability, and pharmacokinetics of Multiple Oral Doses of TAK-831 in Adult...

This study is comparing TAK-831 with placebo for people with Schizophrenia. Participants receive TAK-831 or placebo and complete study visits and assessments.

SchizophreniaOther
Countries
United Kingdom, View results
Sponsor
Takeda Development Centre Europe Ltd.
Condition
Schizophrenia
OngoingEUCTR 2010-018416-33

Effets du Fénofibrate durant la première année de schizophrénie (effects of Fenofibrate® in first year of schizophrenia)

This study is looking at whether FENOFIBRATE MYLAN 200 mg, gélule can help people with schizophrénia or Elderly. Participants receive the study medicine FENOFIBRATE MYLAN 200 mg, gélule and complete study visits and assessments.

SchizophreniaOther
Countries
France
Sponsor
Centre Hospitalier Régional et Universitaire de Lille
Condition
Schizophrenia
CompletedEUCTR 2021-003834-34

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Subjects With Cognitive Impairment Associated With Schizop...

This study is comparing Luvadaxistat with placebo for people with Cognitive Impairment Associated With Schizophrenia. Participants receive Luvadaxistat or placebo and complete study visits and assessments.

SchizophreniaOther
Countries
Czech Republic, Spain, View results
Sponsor
Neurocrine Biosciences, Inc.
Condition
Schizophrenia
OngoingEUCTR 2006-002342-11

Multicenter study of neurotransmitters and neuropeptides in schizophrenia: A multidisciplinary study of biological, pharmacokinetic, receptor occupancy and clinical relationships in patients suffer...

This study is looking at whether Quetiapine can help people with have to fulfill the diagnostic criteria of a schizophrenia according to DSM-IV. Participants receive the study medicine Quetiapine and complete study visits and assessments.

SchizophreniaOther
Countries
Germany
Sponsor
Klinikum Fulda gAG
Condition
Schizophrenia
CompletedEUCTR 2018-003825-27

A Phase 2, Randomized, Double-Blind, Multiple-Dose, Placebo-Controlled Study to Evaluate the Safety and Efficacy of BIIB104 in Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)

This study is comparing BIIB104 with placebo for people with Schizophrenia. Participants receive BIIB104 or placebo and complete study visits and assessments.

SchizophreniaOther
Countries
Germany, United Kingdom, View results
Sponsor
Biogen Idec Research Limited
Condition
Schizophrenia
Schizophrenia | Clinical Trials | HopeStage Research